A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
Abroad (travel likely)RecruitingPHASE2
Conditions
Retinitis Pigmentosa
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Save Sight Institute, Sydney, New South Wales, Australia
Contact: Principal Investigator (John Grigg)Queensland Eye Institute, Woolloongabba, Queensland, Australia
Contact: Principal Investigator (Anthony Kwan)Royal Adelaide Hospital, Adelaide, South Australia, Australia
Contact: Principal Investigator (Robert Casson)Cerulea Clinical Trials, East Melbourne, Victoria, Australia
Contact: Principal Investigator (Doron Hickey)Lions Eye Institute, Nedlands, Western Australia, Australia
Contact: Principal Investigator (Fred Chen)
Study leads
Doron Hickey, MBChB
Principal Investigator
The Centre for Eye Research Australia (CERA)
Robert Casson, MBBS (Hons)
Principal Investigator
Royal Adelaide Hospital